Immorna Biotherapeutics Expands Its R&D Footprint in RTP, NC and Appoints Key Senior Scientific Leaders
RALEIGH, N.C., Jan. 31, 2022 /PRNewswire/ -- Immorna Biotherapeutics, Inc, an immune-oncology drug and viral vaccine development company with both...
Source: businessinsider.com